Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …

Background A safe and efficacious vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of …

Tuberculous meningitis causes substantial mortality and morbidity in children and adults.
More research is urgently needed to better understand the pathogenesis of disease and to …

Background The burden and influence of health-care associated severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections is unknown. We aimed to examine the use …

Background The emergence of meticillin-resistant Staphylococcus aureus (MRSA) that can
persist in the community and replace existing hospital-adapted lineages of MRSA means that …

Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections
worldwide. In the UK alone, around 12 500 cases each year are reported, with an …

Objectives Staphylococcus aureus bacteraemia is a common, often fatal infection. Our aim
was to describe how its clinical presentation varies between populations and to identify …

Importance The latest generation of benchtop DNA sequencing platforms can provide an
accurate whole-genome sequence (WGS) for a broad range of bacteria in less than a day. …

As reported here, whole-genome sequencing has the potential to rapidly facilitate the
determination of antimicrobial susceptibility, especially for slower-growing pathogens, such …

… Estee Török , … Estee Török … Estée Török, and Wendy Snowden (observer). GlaxoSmithKline
Research and Development, UK, provided the following clinical trial supplies for the trial: …